Hypoxia-inducible MiR-196a Modulates Glioblastoma Cell Proliferation and Migration Through Complex Regulation of NRAS

Overview

Journal Cell Oncol (Dordr)

Publisher Springer

Date 2021 Jan 20

PMID 33469841

Citations 10

Authors

Sonam Takkar

Vikas Sharma

Sourabh Ghosh

Ashish Suri

Chitra Sarkar

Ritu Kulshreshtha

Affiliations

Soon will be listed here.

Abstract

Background: Glioblastoma (GBM) is the most common and aggressive malignant brain tumor in humans. Hypoxia has been correlated with the aggressive form of glial tumors, poor prognosis, recurrence and resistance to various therapies. MicroRNAs (miRNAs) have emerged as critical mediators of hypoxic responses and have shown great potential for cancer diagnostics and therapeutics. Here, we focus on the regulatory and functional characterization of miR-196a, a hypoxia-inducible miRNA, in GBM.

Methods: Hypoxia/HIF regulation of miR-196a was assessed by RT-qPCR, promoter-luciferase and ChIP assays in GBM cell lines. miR-196a levels were analyzed in The Cancer Genome Atlas (TCGA)-GBM, Chinese Glioma Genome Atlas (CGGA) and Indian GBM patient cohorts. miR-target interactions were studied using RNA/protein quantification and 3'UTR luciferase assays. The effect of miR-196a overexpression/inhibition was assessed on cellular viability, migration and apoptosis under hypoxia and normoxia. Microarray-based gene expression profiling studies were performrd to study the effect of miR-196a on the GBM cellular transcriptome under hypoxia.

Results: We identified miR-196a as a hypoxia-inducible and hypoxia-inducible factor (HIF)-regulated miRNA that plays an oncogenic role in GBM. miR-196a was found to be significantly up-regulated in TCGA-GBM, CGGA glioma as well as Indian GBM patient cohorts. miR-196a overexpression was found to induce cellular proliferation, migration, spheroid formation and colony formation and to inhibit apoptosis, while miR-196a inhibition using anti-miR-196a yielded opposite results, suggesting an oncogenic role of miR-196a in GBM. We further unveiled NRAS, AJAP1, TAOK1 and COL24A1 as direct targets of miR-196a. We also report a complex competitive regulation of oncogenic NRAS by miR-196a, miR-146a and let-7 in GBM. Analysis of microarray-based gene expression data obtained by miR-196a inhibition under hypoxia revealed a role of miR-196a in HIF, calcium adhesion, Wnt and cell adhesion pathways. Interestingly, miR-196a was found to positively regulate the expression of various genes involved in the induction or stabilization of HIFs and in maintenance of hypoxic conditions, thereby suggesting the existence of an indirect miR-196a/HIF positive feedback loop under hypoxia.

Conclusions: Overall, our work identifies a novel association between hypoxia/HIF signalling and miR-196a in GBM and suggests its therapeutic significance.

Citing Articles

Hypoxia-induced one-carbon metabolic reprogramming in glioma stem-like cells.

He X, Wang J, Shi M, Liu C, Teng Z Life Med. 2025; 2(6):lnad048.

PMID: 39872059 PMC: 11749232. DOI: 10.1093/lifemedi/lnad048.

Bta-miR-181d and Bta-miR-196a mediated proliferation, differentiation, and apoptosis in Bovine Myogenic Cells.

Chengcheng L, Raza S, Zhimei Y, Sihu W, Shengchen Y, Aloufi B J Anim Sci. 2024; 102.

PMID: 38766769 PMC: 11161902. DOI: 10.1093/jas/skae142.

Regulation of Cancer-Associated miRNAs Expression under Hypoxic Conditions.

Valencia-Cervantes J, Sierra-Vargas M Anal Cell Pathol (Amst). 2024; 2024:5523283.

PMID: 38766303 PMC: 11101257. DOI: 10.1155/2024/5523283.

Profiling the autoantibody repertoire reveals autoantibodies associated with mild cognitive impairment and dementia.

Ehtewish H, Mesleh A, Ponirakis G, Lennard K, Hamad H, Chandran M Front Neurol. 2023; 14:1256745.

PMID: 38107644 PMC: 10722091. DOI: 10.3389/fneur.2023.1256745.

Hypoxia in Skin Cancer: Molecular Basis and Clinical Implications.

Jeon S, Jeon M, Choi S, Yoo S, Park S, Lee M Int J Mol Sci. 2023; 24(5).

PMID: 36901857 PMC: 10003002. DOI: 10.3390/ijms24054430.

References

Taylor O, Brzozowski J, Skelding K . Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets. Front Oncol. 2019; 9:963. PMC: 6775189. DOI: 10.3389/fonc.2019.00963. View

Tatum J, Kelloff G, Gillies R, Arbeit J, Brown J, Chao K . Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol. 2006; 82(10):699-757. DOI: 10.1080/09553000601002324. View

Jubb A, Buffa F, Harris A . Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis. J Cell Mol Med. 2009; 14(1-2):18-29. PMC: 3837600. DOI: 10.1111/j.1582-4934.2009.00944.x. View

Seidel S, Garvalov B, Wirta V, von Stechow L, Schanzer A, Meletis K . A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha. Brain. 2010; 133(Pt 4):983-95. DOI: 10.1093/brain/awq042. View

Yang L, Lin C, Wang L, Guo H, Wang X . Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications. Exp Cell Res. 2012; 318(19):2417-26. DOI: 10.1016/j.yexcr.2012.07.017. View

Kalkan R . Hypoxia Is the Driving Force Behind GBM and Could Be a New Tool in GBM Treatment. Crit Rev Eukaryot Gene Expr. 2015; 25(4):363-9. DOI: 10.1615/critreveukaryotgeneexpr.2015015601. View

Said H, Hagemann C, Staab A, Stojic J, Kuhnel S, Vince G . Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo. Radiother Oncol. 2007; 83(3):398-405. DOI: 10.1016/j.radonc.2007.05.003. View

Peng Y, Croce C . The role of MicroRNAs in human cancer. Signal Transduct Target Ther. 2017; 1:15004. PMC: 5661652. DOI: 10.1038/sigtrans.2015.4. View

Ebert M, Sharp P . Roles for microRNAs in conferring robustness to biological processes. Cell. 2012; 149(3):515-24. PMC: 3351105. DOI: 10.1016/j.cell.2012.04.005. View

10.

Ahir B, Ozer H, Engelhard H, Lakka S . MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review. Crit Rev Oncol Hematol. 2017; 120:22-33. DOI: 10.1016/j.critrevonc.2017.10.003. View

11.

Ivan M, Harris A, Martelli F, Kulshreshtha R . Hypoxia response and microRNAs: no longer two separate worlds. J Cell Mol Med. 2008; 12(5A):1426-31. PMC: 3918058. DOI: 10.1111/j.1582-4934.2008.00398.x. View

12.

Kulshreshtha R, Davuluri R, Calin G, Ivan M . A microRNA component of the hypoxic response. Cell Death Differ. 2008; 15(4):667-71. DOI: 10.1038/sj.cdd.4402310. View

13.

Rupaimoole R, Calin G, Lopez-Berestein G, Sood A . miRNA Deregulation in Cancer Cells and the Tumor Microenvironment. Cancer Discov. 2016; 6(3):235-46. PMC: 4783232. DOI: 10.1158/2159-8290.CD-15-0893. View

14.

Agrawal R, Garg A, Malgulwar P, Sharma V, Sarkar C, Kulshreshtha R . p53 and miR-210 regulated NeuroD2, a neuronal basic helix-loop-helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor suppressor under hypoxic microenvironment. Int J Cancer. 2017; 142(9):1817-1828. DOI: 10.1002/ijc.31209. View

15.

Louis D, Ohgaki H, Wiestler O, Cavenee W, Burger P, Jouvet A . The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114(2):97-109. PMC: 1929165. DOI: 10.1007/s00401-007-0243-4. View

16.

Hunt S, McLaren W, Gil L, Thormann A, Schuilenburg H, Sheppard D . Ensembl variation resources. Database (Oxford). 2018; 2018. PMC: 6310513. DOI: 10.1093/database/bay119. View

17.

Messeguer X, Escudero R, Farre D, Nunez O, Martinez J, Alba M . PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics. 2002; 18(2):333-4. DOI: 10.1093/bioinformatics/18.2.333. View

18.

Farre D, Roset R, Huerta M, Adsuara J, Rosello L, Alba M . Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res. 2003; 31(13):3651-3. PMC: 169011. DOI: 10.1093/nar/gkg605. View

19.

Pundir S, Martin M, ODonovan C . UniProt Protein Knowledgebase. Methods Mol Biol. 2017; 1558:41-55. PMC: 5565770. DOI: 10.1007/978-1-4939-6783-4_2. View

20.

Yang G, Han D, Chen X, Zhang D, Wang L, Shi C . MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivo. Neuro Oncol. 2014; 16(5):652-61. PMC: 3984554. DOI: 10.1093/neuonc/not307. View